What Canopy Healthcare does

Canopy Healthcare is a vertically integrated New Zealand healthcare provider headquartered in Auckland, operating through five wholly-owned subsidiaries: Canopy Imaging (over 25 diagnostic imaging clinics across the North Island), Canopy Cancer Care (8 medical oncology clinics, operating since 2010), Auckland Breast Centre (2 private breast surgical and diagnostic centres), Absolute Radiology (specialist radiology in New Plymouth, Taranaki), and iMIX (a GMP-licensed aseptic compounding facility for cytotoxic, CIVAS, and personalized pharmaceutical preparations). The network spans more than 35 clinical facilities from Kerikeri in the Far North to New Plymouth and Hastings, served by over 400 staff including sub-specialty radiologists and oncology clinicians holding ownership stakes in the business. Revenue is generated primarily through professional services fees for diagnostic imaging (MRI, CT, PET-CT, SPECT-CT, mammography, ultrasound, X-ray, DEXA), cancer treatment (chemotherapy and radiation therapy planning), breast diagnostics and surgery, and pharmaceutical compounding.

The group's underlying technology stack combines third-party best-in-class imaging platforms (Siemens MAGNETOM Vida Fit 3T MRI with BioMatrix and Deep Resolve AI, Siemens Mammomat B Brilliant with TiCEM for contrast-enhanced mammography, Rhenium SCT for skin cancer) with AI vendor integrations (Gleamer BoneView for fracture detection, AI-driven MRI reconstruction). Business model revenue is split across direct patient-funded episodes, private health insurance reimbursements, ACC claims, and public health system (Te Whatu Ora | Health New Zealand) contracts for partnered service delivery, with self-referral options offered for designated services such as DEXA bone density scans. Patient access is driven primarily through GP and specialist referrals, supplemented by online booking and direct patient engagement.

The business is backed by ICG (Investment Group) and governed by a board, with significant clinician ownership aligning clinical decision-making with equity participation. Operational expansion has accelerated through 2024-2026, including the Kerikeri opening in 2024, co-located cancer care and imaging at Kaweka Hospital (Hastings) in September 2025, the Ahuriri clinic in September 2025, the Ormiston MRI installation in December 2025, and an announced first permanent PET-CT service in Palmerston North for August 2026. The group has additionally achieved Toitū CarbonReduce certification (May 2025) and SBTi validation of emissions reduction targets (November 2025), and has received the highest global NPS rankings in its category from the 2025 Cemplicity Benchmarking Report for three of its operating entities.

Name

Canopy Healthcare

Legal name

Canopy Healthcare

Website

https://canopyhealthcare.co.nz

Company type

Private

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Canopy Healthcare is a vertically integrated New Zealand healthcare provider operating over 35 diagnostic imaging, oncology, breast care, and pharmaceutical compounding facilities across the North Island, serving referred and self-referring patients, private insurers, and the public health system.

Ownership category

akta.pro rank

Headquarters

HQ city

Auckland

HQ country

New Zealand

HQ region

Oceania

Offices8 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. Diagnostic Imaging Services: Revenue from providing diagnostic imaging services including MRI, CT, X-ray, ultrasound, mammography, bone density scans, and PET-CT scans to referred patients and public health system.
2. Oncology Treatment Services: Revenue from providing cancer treatment and care services including chemotherapy, radiation therapy planning, and related oncology consultations at 8 oncology clinics.
3. Breast Diagnostic and Surgical Services: Revenue from breast diagnostics, surgery, and related services at 2 private breast surgical and diagnostic centres.
4. Pharmaceutical Compounding: Revenue from GMP Licensed Aseptic Compounding services including Cytotoxic, CIVAS and Aseptic Compounding for personalized treatment solutions.
5. Insurance and ACC Funded Care: Revenue from private health insurers and ACC for funded patient treatment episodes.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

Canopy Healthcare is a vertically integrated New Zealand healthcare provider that operates a network of diagnostic imaging clinics (Canopy Imaging), medical oncology clinics (Canopy Cancer Care), private breast surgical and diagnostic centres (Auckland Breast Centre), regional radiology services (Absolute Radiology), and a pharmaceutical compounding business (iMIX). Services include MRI, CT, PET-CT, X-ray, ultrasound, mammography, DEXA bone density scanning, chemotherapy, breast surgery, skin cancer therapy, and personalized aseptic compounding.

Product overview

Canopy Healthcare is a vertically integrated New Zealand healthcare provider offering a comprehensive portfolio of services through its subsidiary brands. The organization operates Canopy Imaging (diagnostic imaging across MRI, CT, X-ray, ultrasound, PET-CT, mammography, DEXA, and AI-assisted diagnostics), Canopy Cancer Care (medical oncology treatment), Auckland Breast Centre (breast diagnostics and surgery), Absolute Radiology (Taranaki radiology services), and iMIX (aseptic pharmaceutical compounding). The services are interconnected: Canopy Imaging provides diagnostic capabilities that support cancer diagnosis and treatment planning at Canopy Cancer Care, while iMIX provides specialized pharmaceutical preparations including cytotoxic compounds for cancer treatment. The network spans 25 diagnostic clinics, 8 oncology clinics, and 2 breast surgical centres across the North Island, with significant clinician ownership.

Differentiator

Problem solved

Functional benefit

Products and services

• Canopy Imaging Leading diagnostic imaging provider combining advanced imaging technology with sub-specialty radiology expertise. Offers MRI, CT, X-ray, ultrasound, PET-CT, SPECT-CT, mammography, bone density (DEXA), body composition scans, and AI-assisted diagnostics through over 25 diagnostic clinics across North Island New Zealand.
• Canopy Cancer Care Medical oncology provider delivering cancer treatment and care services including chemotherapy, targeted therapies, and integrated care across 8 oncology clinics in New Zealand.
• Auckland Breast Centre Private breast surgical and diagnostic centre providing comprehensive breast healthcare including mammography, 3D tomosynthesis, contrast-enhanced mammography (CEM), ultrasound, biopsy, and breast surgery services across 2 centres.
• Absolute Radiology Specialist radiology clinic serving Taranaki region from New Plymouth, offering medical imaging services including MRI, CT, ultrasound, and X-ray in a convenient, friendly, and patient-focused environment.
• iMIX GMP Licensed Aseptic Compounding service providing personalized treatment solutions including Cytotoxic, CIVAS, and Aseptic Compounding with over 50 years of combined compounding experience.
• Rhenium SCT Skin Cancer Therapy Non-invasive, single-session beta radiation treatment for superficial non-melanoma skin cancers (BCC, SCC). Uses radiotherapeutic paste applied via protective foil for targeted treatment with minimal impact on surrounding tissue.
• Contrast Enhanced Mammography (CEM) Advanced breast imaging technique combining 3D Tomosynthesis with intravenous iodine-based contrast dye using dual-energy imaging to provide both structural and functional information, highlighting areas of increased blood flow associated with cancer.
• DEXA Bone Density Scanning Bone density and body composition scanning service using DEXA technology. Available at multiple Canopy Imaging locations for osteoporosis detection, bone health assessment, and detailed body composition analysis. Self-referral available for eligible patients.

Quantifiable outcome

• NPS: 92 - highest globally and in APAC for outpatient group providers (Canopy Cancer Care)
• +3 more outcomes

Named customers4 records

Segments6 records

Ideal customer profiles6 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature6 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• Siemens HealthineerscoreTechnology or Integration · 1 December 2025Equipment supplier providing state-of-the-art MRI technology including MAGNETOM Vida Fit 3T MRI systems. Partnership enables sustainable technology upgrades that reduce waste and energy consumption by up to 40%.
• Kaweka HospitalcoreStrategic or Co-development Partner · 1 September 2025Co-location partnership enabling integrated cancer care and diagnostic imaging services under one roof at Kaweka Hospital Stage 2 development. First regional PET/SPECT scanner installed late 2024 at this location.
• Local Iwi (Māori)minorStrategic or Co-development Partner · 1 September 2025Local iwi provided cultural guidance and blessed the Ahuriri clinic site, reflecting Canopy Imaging's commitment to respectful, inclusive care in partnership with indigenous communities.
• CemplicitycoreStrategic or Co-development Partner · 1 January 2025Partnership for patient experience benchmarking enabling real-time feedback collection and NPS measurement across all Canopy Healthcare providers. This partnership enables continuous improvement based on patient experience data.
• Te Whatu Ora | Health New ZealandcoreStrategic or Co-development PartnerPublic health system partnership for radiology systems, electronic health records (TestSafe), and partnered service delivery. Canopy provides services on behalf of the public system as done in Whangārei.
• Private Health InsurerscoreOthersHealth insurance providers funding private treatment episodes. CH shares requested information relating to care episodes with health insurance providers and ACC for funded treatments.
• Drug Company Cost Share ProgrammesminorOthersPartnership with pharmaceutical companies for cost share programmes where patient details may be required for enrolment (Canopy patients only).
• ACC (Accident Compensation Corporation)coreOthersGovernment accident compensation scheme partnership for funded treatment episodes. CH shares information with ACC for privately funded treatments under ACC coverage.

Scale indicators12 records

Recent moves14 records

Expansion highlights7 records

Direct peers

• Mercy Radiology: Auckland-based private radiology group offering diagnostic imaging services including MRI, CT and mammography. Direct competitor in the Auckland market where Canopy Imaging operates the Ormiston, Milford and Botany clinics.
• Pacific Radiology: One of New Zealand's largest private diagnostic imaging providers operating across multiple regions with MRI, CT, ultrasound and mammography services. Directly comparable to Canopy Imaging as a private NZ imaging network competing for the same GP/specialist referrals and insurer contracts.
• SRG Radiology: New Zealand-wide specialist radiology network providing diagnostic imaging to referred patients across multiple regions. Comparable to Canopy Imaging in referral-based GTM, modality mix, and private/public funding model.
• Auckland Radiation Oncology (ARO): Private radiation oncology provider in New Zealand delivering radiotherapy and related cancer services. Comparable to Canopy Cancer Care's outpatient medical oncology offering within the broader private NZ oncology ecosystem.

Broad incumbents

• I-MED Radiology Network: Australia's largest private diagnostic imaging network with hundreds of clinics offering MRI, CT, PET-CT and nuclear medicine. Comparable as a scaled private radiology network model relevant to Canopy's growth trajectory.
• Southern Cross Healthcare: New Zealand's largest private healthcare network operating hospitals and specialist centres including surgical and diagnostic services. Comparable as a broader private healthcare incumbent with overlapping surgical, breast and diagnostic offerings across NZ.
• Healius: ASX-listed Australian healthcare operator encompassing diagnostic imaging (Lumus), pathology and day hospitals. Comparable as a vertically diversified diagnostics and ambulatory care operator in a trans-Tasman market.
• Sonic Healthcare: Global diagnostics giant with significant Australasian radiology and pathology operations. Comparable as a scaled trans-Tasman diagnostics incumbent relevant to Canopy's vertically integrated diagnostic + compounding model.

Others

• Canopy Cancer Care (internal benchmark): Listed only for completeness as Canopy's own oncology subsidiary; comparable benchmarks include other NZ private oncology providers such as the oncology services at Auckland Radiation Oncology and Southern Cancer Society for outpatient chemotherapy delivery.

Regional players

• Bay Radiology: Specialist radiology provider serving the Bay of Plenty region with MRI, CT and ultrasound services. Operates in an adjacent North Island geography to Canopy Imaging with comparable modality mix and referral-driven model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/canopy-healthcare

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Canopy Healthcare